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Three-dimensional analysis of enlarging aneurysms
after endovascular abdominal aortic aneurysm
repair in the Gore Excluder Pivotal clinical trial
Mark Fillinger, MD, for the Excluder Bifurcated Endoprosthesis Clinical Investigators, Lebanon, NH
Objective:Recent reports have raised concern about the percentage of enlarging abdominal aortic aneurysms (AAAs) after
endovascular repair with the Gore Excluder device. As part of the investigation into this issue, a morphologic analysis was
performed on enlarging aneurysms in the Excluder Pivotal clinical trial.
Methods:Computed tomographic scans were evaluated on all patients identified with enlarging aneurysms (5-mm increase
by Core laboratory or site) and at least 4 years of follow-up in the Excluder Pivotal clinical trial. Three-dimensional
reconstruction, a set of 24 standard morphologic measurements, and analysis of potential enlargement mechanisms were
performed.
Results:Of 112 trial patients with 4 years of follow-up, 38 AAAs (34%) were identified as enlarging. Data were obtained
from 196 computed tomographic scans (the mean interval was 47 months from first to last scan). Of the 158 scans with
a prior scan for comparison, 41% demonstrated growth relative to the initial scan by diameter criteria, but 79%
demonstrated growth relative to the initial scan by 3-dimensional volume criteria (P < .0001 vs diameter; 2 analysis).
This difference was most evident at early time points: at 1 year, diameter criteria indicated that 8% of these AAAs were
enlarging, but 56% were already enlarging by volume criteria. On average, enlargement was detected by volume 18
months before it was detected by diameter (P< .0001), and at a smaller diameter (55 1mm vs 60 1mm; P< .0001).
Only 19% of scans (39% of patients) had apparent endoleaks. Scans with apparent endoleaks demonstrated a greater
interval rate of growth as compared with those without apparent endoleak (3.6 0.8 mm vs 1.9 0.3 mm [P< .02] by
diameter; 23  4 cm3 vs 11  1 cm3 [P < .001] by volume). Although the etiology of enlargement may be endotension
or device permeability in up to 74% of patients, other potential causes of aneurysm enlargement included neck apposition
length less than 15 mm (15 patients; 39%), large aortic diameter relative to device (18%), large iliac diameter (5%), and
iliac apposition length less than 15 mm (20%). Multiple potential etiologies of enlargement were present in 53% of AAAs.
Conclusions: The etiology of aneurysm enlargement in the Excluder Pivotal trial is likely multifactorial, including
endoleak, inadequate attachment site length, and endotension or device permeability. Even by conservative criteria, a
substantial percentage of aneurysm growth with the original device is likely due to material permeability. Three-
dimensional volume criteria detected aneurysm enlargement more frequently, at a smaller diameter, and on average 18
months sooner than standard diameter criteria, thus suggesting a role in further investigation of this issue. (J Vasc Surg
2006;43:888-95.)Recent reports have raised concern about the percent-
age of enlarging abdominal aortic aneurysms (AAA) after
endovascular repair with the Gore Excluder device (WL
Gore, Flagstaff, Ariz).1-3 This led to an extensive investiga-
tion into potential causes of AAA enlargement, with the
conclusion that graft material permeability in the original
Excluder device may be the etiology of aneurysm sac en-
largement in a significant number of cases. As part of this
investigation, a more detailed analysis of the enlarging
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888aneurysms in the original Excluder clinical trial was also
undertaken. This report represents a morphologic analysis
of the subset of patients with enlarging aneurysms at the
4-year time point in the Excluder Bifurcated Endoprosthe-
sis 98-03 Pivotal clinical trial,4 based on computed tomog-
raphy (CT) scans, three-dimensional reconstruction, and
morphologic measurements.
METHODS
Patient population and data supplied. CT scans
were evaluated on all patients identified with enlarging
AAAs (a 5-mm increase by Core laboratory or site) and at
least 4 years of follow-up in the Excluder 98-03 Pivotal
clinical trial (2004 Annual Clinical Update Report). All
patients participating in the trial received informed consent
in institutions with institutional review board approval for
the study, and all patients met anatomic selection criteria at
the time of enrollment (1998-2000) by using the imaging
methodology available at the time. CT scans for this subset
of patients with enlarging AAAs were sent to Medical
Metrx Solutions (West Lebanon, NH) for three-
dimensional reconstruction. A set of 24 standard morpho-
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potential enlargement mechanisms by using morphologic
data, 3-dimensional reconstructions, and data regarding
secondary interventions and diameter changes reported by
each site relative to the clinical trial.
Definitions and criteria for evaluation. The maxi-
mum AAA sac diameter was measured as the maximum
AAA diameter on CT reformat perpendicular to the lumen
centerline. AAA size change was measured both relative to
the initial postoperative CT scan and as the interval change
from the previous scan. Three-dimensional volume was
measured from the lowest renal artery to the aortic bifur-
cation and from the lowest renal artery to the common iliac
artery bifurcation (to capture iliac aneurysms). Total vol-
ume was based on three-dimensional reconstruction of CT
data for the outer boundary of the vessel, including lumen,
thrombus, calcified plaque, andmetallic stent. For diameter
change, 5 mm or more was considered to be a significant
change (based on interobserver variability more than 3 mm
and Society for Vascular Surgery [SVS] reporting stan-
dards).5-7 For three-dimensional volume change, 5% or
more was considered significant, based on SVS reporting
standards6,7 and our interobserver variability of 2.5%.
Other parameters for evaluation included aortic neck
length, neck diameter at multiple sites, and achieved aortic
neck apposition (100% circumference); initial aneurysm sac
diameter; iliac length, diameter (maximum and average),
and achieved apposition length (all for both right and left
iliacs); aortic neck angulation; device angulation over time;
endoleak during the interval being examined; and endoleak
at any time. These measurements were defined and re-
ported according to SVS reporting standards.6
Techniques. Morphologic assessment was made by
using three-dimensional computer-aided measurement,
planning, and simulation technology.8-10 Measurements
were made by using electronic calipers on digital CT data
with multiplanar CT reformats, including orthogonal re-
formats for diameter. Length and angle measurements
weremade along the lumen centerline in three-dimensional
space. CT scan techniques and intervals were according to
institutional protocols, with guidance within the parame-
ters of the 98-03 study.4
Statistical methods. Anatomic measurements were
analyzed with a standard statistical software package (Stat-
View; SAS Institute, Cary, NC). Nominal variables were
compared by 2 or Fisher exact test where applicable.
Continuous variables were analyzed by using analysis of
variance and linear regression.
RESULTS
Patient population. Of the 235 test patients in the
98-03 trial, 112 patients were identified with 4-year
follow-up (site reported; last update August 2005). Of
these, 38 AAAs (34%) were identified as enlarging at some
point during the course of follow-up, most at 3- to 4-year
follow-up by site or Core laboratory (36 of 38 in agree-
ment). Data were obtained from 196 CT scans, with a
mean interval of 11.2 months between scans and a mean of47 months from first to last scan. Only seven scans were
unavailable or unusable from routine follow-up. When
compared with the overall population of AAAs undergoing
endovascular aneurysm repair in the trial, the key baseline
anatomic characteristics seem similar for this subset of
enlarging aneurysms (Table I).
Mean diameter and volume over time and detection
of enlargement. As would be expected in a study of aneu-
rysms identified to be enlarging, both diameter and volume
increased over time. The mean diameter change between
scans was 2.3  0.3 mm, compared with a 9.0%  0.9%
mean volume change. The apparent growth relative to the
threshold for detection was quite different for the two
techniques. Most aneurysms did not enlarge beyond the
threshold for detection by diameter until 3 years of follow-
up, as shown in Fig 1. This is consistent with data reported
for the trial, in which only 6 of these 38 aneurysms were
identified as enlarging by 2 years of follow-up. By contrast,
most aneurysms enlarged beyond the threshold for three-
dimensional volume detection by 1 year of follow-up, as
shown in Fig 2. This difference in the two techniques is
demonstrated by the percentage of aneurysms identified as
enlarging at each time point (Fig 3). In this study, 11
aneurysms (of 38) were identified as enlarging by diameter
at 2 years, compared with 6 by site-reported diameter data
and 30 by 3-dimensional volume (Fig 3). On average,
enlargement was detected by volume 18 months before it
was detected by diameter (18  2 months vs 36  2
months; P  .0001), and at a smaller diameter (55.4  1
mm vs 59.8  1 mm; P  .0001).
Early in the Pivotal trial, a criterion of a 3-mm diameter
change was attempted but was found to result in a number
of false positives (aneurysms reverting back and forth be-
tween enlarging and shrinking on subsequent studies), so
the criterion of 5 mm was adopted, according to the SVS
reporting standards. Even with a diameter threshold below
typical interobserver variability, however, the percentage of
AAAs identified as enlarging was lower by diameter (Table
II). Volume criteria have always been reported as a percent-
age, but for comparison, using a 5% threshold for diameter
was also significantly worse than using the three-
dimensional volume (Table II). Even a volume criterion of
10% change identified 68% of AAAs increasing relative to
the first scan, which is still significantly better than the
3-mm or 5% diameter criteria (P  .03).
Endoleak as a potential cause of AAA enlargement.
Only 18% of the scans (36 of 196) had apparent endoleak,
but scan protocols, including contrast timing, slice thick-
ness, and a lack of three-phase or delayed contrast studies,
likely underestimated the true percentage of cases with
endoleak. On the basis of endoleak at any time point, 39%
of patients (15/38) had an AAA with an endoleak on at
least a single scan. All of the endoleaks seemed intermittent
to some degree, but in three patients only a single scan out
of the entire series lacked endoleak, and this seemed to be
due to poor contrast density rather than a true lack of
endoleak. At least some endoleaks were likely transient,
however, because 5 of these 15 patients had endoleaks that
h was
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longer visible on multiple scans. Almost all endoleaks
seemed likely to be type II, and only one potential type I
endoleak was reported.
Despite concern about visualizing all endoleaks, AAAs
with apparent endoleak demonstrated roughly twice the
interval rate of growth as compared with AAAs without
apparent endoleak (Table III). The comparison for rate of
growth is affected by initial aneurysm size, which was larger
in patients with endoleak, but there is still a significant
trend even when evaluation is performed by volume per-
centage (Table III). Aneurysm growth was not propor-
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Fig 1. Mean diameter change compared with initial computed
tomography.
Table I. Comparison of baseline measurements for the en
Measurement (based on first scan applicable)
AAA maximum diameter (mm)
AAA volume renal-aobif (cm3)
AAA volume renal-hypo (cm3)
Ao neck diameter (mm)
Ao neck diameter 15 mm distal to lowest renal artery (mm)
Ao neck length
Achieved aortic neck apposition by stent graft
Distance lowest renal to top of graft (mm)
Neck angulation (neck to AAA) (°)
Aortic angle suprarenal aorta to infrarenal aorta
R common iliac diameter
R CIA maximum diameter
R iliac apposition length
L common iliac diameter
L CIA maximum diameter
L iliac apposition length
EVAR, Endovascular aneurysm repair; AAA, abdominal aortic aneurysm
Common Iliac Artery; NA, Not Available or Not Applicable; aobif, aortic bi
in degrees, all volumes in cc (cm3).
P values are not applicable because measurement methods were not the sam
tomography for three-dimensional reconstruction, preoperative neck lengt
tomography scan for most cases in the enlarging group.tional to endoleak size, whether for interval AAA diameterchange vs endoleak volume (P .66), interval AAA volume
change vs endoleak volume (P  .37), or diameter or
volume change relative to initial scan vs endoleak volume (P
 .4-.9). Thus, interval AAA growth seemed to be related
to the presence or absence of endoleak but did not seem to
correlate with the size of the endoleak in this series.
Association with other morphologic criteria and
possible endotension. Examination of the data in Table I
indicates that most patients met the inclusion criteria in
terms of preoperative anatomy, even with the three-
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%
Fig 2. Mean three-dimensional volume change compared with
initial computed tomography. Three-dimensional volume is
shown from lowest renal to aortic bifurcation. The graph for
volume from renal to hypogastric seems similar (eg, the volume
change from renal to hypogastric is 45% at 4 years rather than 40%).
ng group and entire Pivotal trial (EVAR patients)
Enlarging group
(n  38)
EBE Pivotal trial (EVAR patients;
n  235)
53.5  1.4 55.6  0.6
140  11 NA
157  11 NA
22.4  0.4 22.3  0.1
23.5  0.5 NA
NA 28.9  0.7
18.8  2.0 NA
0.5  1.2 NA
30.0  0.6 22.0  1.1
13.2  1.4 NA
12.8  0.4 12.4  0.2
16.2  0.5 NA
32.1  4.0 NA
12.7  0.4 11.8  0.2
15.9  0.7 NA
28.5  2.6 NA
aortic; R, right; L, left; EBE, Excludes Bifurcated Endoprosthesis; CIA,
on; hypo, hypogastric artery. All diameters and lengths are in mm, all angles
cause of the number of patients without adequate preoperative computed
not reported. Baseline measurements are from the 1-month postoperativelargi
; Ao,
furcati
e. Bedimensional computer-aided measurement technology.
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meet desirable goals for fixation and sealing parameters.
In terms of achieved aortic neck apposition length, 15
(39%) of 38 patients had a neck apposition length less than
15mm at some point during follow-up. Using a criterion of
100% circumference neck apposition greater than 5 mm in
length, six patients (16%) may have had poor neck apposi-
tion as a factor in aneurysm growth. Many patients did not
have a preoperative scan available and adequate for three-
dimensional reconstruction, so the percentage who started
out with inadequate available neck length is unclear. At
least one patient clearly could not have had an acceptable
neck initially (Fig 4). The device was implanted immedi-
ately below the renal arteries, there was no apparent en-
doleak, and the AAA diameter was stable for 3 years, but the
AAA volume increase was apparent by 1 year and thereafter.
It seems that three patients had devices initially implanted
more than 1 cm distal to the lowest renal artery despite a
neck thatmet trial inclusion criteria before surgery. In other
cases there was thrombus, diameter change (neck enlarge-
ment), and/or angulation within the apparent infrarenal
neck that seemed to diminish the length of neck apposition.
At least one neck apposition length decreased as a result of
aneurysm growth over time (Fig 5). This patient had no
apparent endoleak on any postoperative study but did have
early suboptimal iliac fixation that may have produced
sufficient endotension to cause aneurysm growth.
Aortic neck dilation. Infrarenal aortic neck diameter
just proximal to the top of the graft seemed to meet
inclusion criteria (26 mm) in all but two patients on the
initial postoperative scan but exceeded inclusion criteria by
at least .5 mm in seven patients (18%) at later time points.
The neck diameter 15 mm below the renal arteries also met
inclusion criteria on the initial postoperative scan in 36 of
38 patients but was 28 mm or more at later time points in
25 scans (16%) and 9 patients (24%). Both of these param-
7% 8%
29%
65%
95%
47%
56%
79%
94%
100%
0%
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3-D Volume
Fig 3. Percentage of enlarging abdominal aortic aneurysms over
time. A comparison of the percentage of enlarging aneurysms by
diameter and volume criteria is shown at each time point. 3-D,
Three-dimensional.eters suggest a mild dilation of the neck, common with allendografts, and this did not seem to be a common etiology
of sac enlargement in this series.
Iliac attachments. Iliac artery diameters were initially
at least 1 mm larger than inclusion criteria at the site of
apposition in 14 (37%) of 38 patients, on the basis of the
outer diameter (including stent). Lumen diameter, not
outer wall diameter, was used for inclusion criteria in the
trial, and the lumen diameter likely met inclusion criteria in
most cases. Thus, iliac endograft sizing was an unlikely
cause of aneurysm growth, even considering endotension
without endoleak. In terms of iliac apposition length, six
limbs had inadequate apposition length (clearly 15 mm)
at some point during follow-up, and nine other limbs had
possibly inadequate apposition length at some point during
follow-up. Thus, at most 15 (20%) of 76 limbs had a
possibly inadequate fixation/seal length at some point dur-
ing follow-up. Two patients with such limbs are shown in
Fig 6. Several of these cases could theoretically have had
pressure transmission through thrombus, but this was not a
likely etiology of aneurysm enlargement in most patients.
Other morphologic factors. Other factors from the
literature or trial inclusion/exclusion criteria were present
in small numbers. In one patient, mild angle changes
allowed the neck-AAA body angle to reach 60°, but this
was not a source of endoleak or other problems. There was
progressive device deformation (defined as progressive an-
gulation  15°) in only one patient, and it also did not
cause endoleak or fixation problems. Angle changes were
minimal on average. Angulation from neck to aneurysm
body was 30°  2° on initial scan and 33°  3° at 4 years.
Only one case had significant migration (5 mm) at any
time during follow-up (migration of 7 mm in 3 years), and
this did not decrease the aortic neck apposition to less than
15 mm or result in endoleak. For all 38 patients, the mean
distance from the lowest renal artery to the top of the graft
changed from 0.5 1.2mm on the initial scan to a mean of
2  0.6 mm on all remaining scans, with no significant
change by analysis of variance for distance over time at
yearly intervals. There were no stent fractures and no rup-
tures.
Summary of potential etiologies of enlargement.
Each AAA was labeled with potential etiologies of enlarge-
ment by the described criteria: 53% had multiple potential
etiologies (endoleak or endotension due to transmission of
pressure through thrombus at one or more attachment
sites), 26% had endoleak as the only clear potential etiology,
and 21% of AAAs had no apparent explanation for growth
other than endotension due to material permeability issues.
Secondary interventions. In all, 17 of the 38 patients
had a secondary intervention of some type. There were 13
coil embolizations, 1 inferior mesenteric artery ligation, 1
case with extensions, and 4 explants (2 patients had more
than 1 intervention). In terms of treating endoleaks, only
four coil embolizations seemed successful in obliterating
the endoleak, but in each case, aneurysm expansion did not
stop or slow. In fact, in three of the four cases in which
endoleak was no longer apparent, the rate of aneurysm
expansion seemed to increase by volume (although not by
ompar
pture
rval be
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aneurysm that did not seem to have poor device apposition
at the attachment sites or an attachment endoleak. Of all
the patients with secondary interventions, 15 of 17 had a
follow-up scan. Of these, only the four explants were suc-
cessful in treating expansion. Notably, in three of the four
explants, there was no apparent endoleak at any time,
including examination of the sac at the time of explanta-
tion.
DISCUSSION
In this study, three-dimensional morphologic analysis
indicates that multiple factors may be contributing to AAA
enlargement after endovascular repair with the Gore Ex-
cluder device. The importance of each potential factor is
open to interpretation, however, including the presence of
endoleak. It thus seems important that the data in this study
indicate that the interval rate of aneurysm growth was 50%
to 100% greater in the scans with apparent endoleak com-
pared with the scans with no apparent endoleak. This
suggests that endoleak is important in at least some cases,
despite some controversy on this issue. Nonetheless, only
39% of these patients had an endoleak at any time during 4
years of follow-up, and in 5 of the 15 AAAs with endoleak,
the endoleak was apparent only in the first 1 or 2 scans and
then was no longer visible on multiple subsequent scans.
Either the endoleak was missed on later scans or the late
aneurysm growth seen in each of these patients was due to
another cause. In three of the four cases that went on to
open surgical explantation of the endograft, no endoleak
was detected upon direct examination of the sac (and in the
fourth, endoleak was demonstrated on CT before explan-
Table II. Percentage of scans with increasing abdominal a
Criterion % with interval sac increase (
Diameter, 5 mm 22
Diameter, 3 mm 36
Diameter, 5% change 39
Volume, 5% (renal-aobif) 58
Volume, 5% (renal-hypo) 56
Volume, 5% (either) 61
aobif, aortic bifurcation; hypo, hypogastric artery.
Data are based on 158 computed tomographic scans with a prior scan for c
initial scan (2). Volume 5% (either) refers to either volume criterion, to ca
Table III. Rate of aneurysm growth based on apparent en
Variable N
Interval diameter increase, (mm)
Interval volume increase, renal-aobif (cm3) 1
Interval volume increase, renal-hypo (cm3) 1
Interval diameter increase (by %)
Interval volume increase, renal-aobif (%)
Internal volume increase, renal-hypo (%)
aobif, aortic bifurcation; hypo, hypogastric artery.
Interval indicates the change compared with the prior scan. The mean intetation). Thus, it seems that endoleak can explain only aminority of the cases of aneurysm enlargement in these
patients.
Multiple patients in this study seem to have inadequate
attachment site apposition length according to current
recommendations of appropriate pretreatment anatomy,
which are of course somewhat arbitrary. The values chosen
for adequate postoperative apposition length have been
found to be important relative to endoleak and stable
fixation for other devices, however.11,12 To the extent that
there is no apparent endoleak, the potentially inadequate
apposition may be only a theoretical concern, because this
requires endotension by transmission of pressure through
thrombus at the attachment site, without endoleak. Of
course, these may simply be cases of missed endoleak, but
that does not explain the lack of endoleak at the time of
explantation in this trial and in multiple other studies.13-15
It is interesting that the aneurysm growth in these endo-
tension cases was significantly slower than in the cases with
visible endoleak. Perhaps this means that slow endoleaks
undetected on CT without delayed contrast runs have a
lower pressure than endoleaks visible on arterial-phase
contrast-enhanced CT. Perhaps it means that pressure
transmission through thrombus or by material permeability
and transmigration of fluid occurs at a lower pressure than
type II endoleaks. This analysis cannot answer these ques-
tions.
Very little is known about aneurysm enlargement due
to material permeability, sac hygroma, or transmigration of
fluid. It seems that this phenomenon can happen after
endovascular or open repair, with polytetrafluoroethylene
or polyester fabrics, and can even occur via the wall of the
aneurysm in the absence of graft material.13-18 Although
aneurysm sac size at any time
cans) % with sac increase since initial scan (158 scans)
41
51
56
78
76
79
ison. P  .0001 for all diameter criteria vs volume for detection relative to
changes in iliac aneurysms.
ak or lack thereof
oleak Endoleak P value
0.3 3.6  0.8 .02
1.3 22.0  4.1 .002
1.4 23.4  4.4 .001
0.5 5.7  1.3 .12
0.9 12.3  2.2 .04
0.8 11.9  2.2 .02
tween scans was 11.2 months.ortic
158 sdole
o end
1.9 
1.1 
1.3 
3.6 
7.9 
7.1 believed by many to be benign, it can cause aneurysm
rysm
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way to infer or even estimate how many cases of enlarge-
ment might be due to graft permeability, in part or in
whole? At a minimum, 21% of the cases in this study have
no obvious explanation for aneurysm growth, even with a
detailed three-dimensional analysis including numerous
morphologic factors over time. Logically, enlargement in
these cases is very likely due to graft permeability and
transmigration of fluid. In the aneurysms with multiple
Fig 4. Initially inadequate infrarenal aortic neck with th
model.
Fig 5. Decrease in neck apposition length due to aneupotential etiologies, permeability may have at least a partialinfluence, because many cases with suboptimal apposition
length (15mm) are unlikely to have so little apposition as
to allow pressure to be transmitted at the attachment site.
Thus, one might set an upper limit of 74% in which perme-
ability may be in important issue. This assumes that perme-
ability is not even a partial factor in the 26% of cases with
persistent or “late” type II endoleak and no attachment site
issues. The latter assumption is likely true, but it should be
noted that the rate of aneurysm enlargement did not cor-
bus both solid and transparent in the three-dimensional
growth. This patient also had suboptimal iliac fixation.romrelate with endoleak size in this study as it has in others,19
leak.
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doleak cases.
In terms of other issues, the problems demonstrated in
this analysis related to initial imaging, patient selection,
device sizing, intraoperative device placement, and attach-
ment site enlargement should be similar from one device to
another. These problems can be minimized with good
preoperative imaging for patient selection and evaluation of
potential device issues,8,10 as well as proper intraoperative
imaging (eg, gantry adjustment for neck angulation).8,9
There is no reason to believe that these issues should be
significantly different for the Excluder device, however.
Certainly, the data in this study for placement relative to the
renal arteries, our own experience,10,20 and the trial results4
Fig 6. Potentially inadequate iliac apposition length fo
open repair for aneurysm growth in the absence of endosuggest that the device is readily placed at the desiredlocation. Data from a meta-analysis of four clinical trials
indicate that neck dilation can be associated with migra-
tion, but this is uncommon and is not significantly different
between devices.21 Thus, the difference in the percentage
of aneurysm enlargement, or even lack of shrinkage, be-
tween the original Excluder and other devices could be due
to permeability issues. Bertges et al1 found that the rate of
aneurysm enlargement for the original Gore Excluder was
not significantly different fromAncure (Guidant, Indianap-
olis, IN) or Talent (Medtronic, Minneapolis, MN) at 2
years, but the incidence of shrinking aneurysms was 30%
lower at 2 years with the Excluder device. Kong et al15
studied 16 Excluder explants and found 7 with endoleak (2
had been assumed endotension) and 6 documented endo-
tion and sealing. This patient went on to conversion tor fixatension cases. Both studies fit within our estimate of the
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meability.
One of the problems in evaluating this problem is that
nearly all reports from clinical trials report size changes by
using diameter. It is clear from this study that three-
dimensional volume criteria detected aneurysm enlarge-
ment more frequently, at a smaller AAA size, and on
average 18 months sooner than standard diameter criteria.
Notably, site-reported diameter data detected enlargement
at an even lower rate than the standardized diameter data
derived from orthogonal CT reformats in this study. Thus,
current reports based on diameter assessment of any kind
seem to underestimate the true percentage of enlarging
AAAs with this endograft and other endografts, especially
at early time points. This has obvious implications not only
for routine clinical care, but also for clinical trials. Clinically,
three-dimensional reconstruction is commercially available
frommultiple sources and remains the gold standard, as has
been suggested by ourselves and others.9,10,22,23 With
regard to clinical trials of new devices, these data indicate
that in the absence of three-dimensional reconstruction,
longer-term follow-up might be justified before commer-
cial release.
CONCLUSIONS
The etiology of aneurysm enlargement in the Excluder
Pivotal trial is likely multifactorial, including endoleak,
endotension due to inadequate attachment site length, and
endotension due to material permeability. Even by conser-
vative criteria, a substantial percentage of aneurysm growth
with the original device is likely due to material permeabil-
ity. Three-dimensional volume criteria detected aneurysm
enlargement more frequently, at a smaller diameter, and on
average 18 months sooner than standard diameter criteria,
thus suggesting a role in further investigation of this issue.
At this point, data are being collected in an ongoing study
of the newer low-permeability Excluder device, which will
likely answer the questions regarding material permeability
with the original Gore device.
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